New Social Media Regulatory Framework                A Critical Analysis
At the recent eyeforpharma “2nd Annual eCommunication and Online Marketing” conference, Fard Johnmar (Founder, Envision Solutions), Jim Nail (CMO, TNS Media Intelligence/Cymfony), and John C. Serio, (partner, Seyfarth Shaw LLP) talked about regulatory issues relating to Web 2.0 and summarized a new social media monitoring and marketing framework for pharmaceutical companies (“New Social Media Marketing Framework White Paper”). 
This article takes a critical look at the “Framework” and offers further insights into the regulatory issues it raises.
Topics and issues covered include:
- Fair Balance and the “One-Click Rule”
 - Jim Nail’s Comments on “One Click Rule”
 - With Respect to Internet Guidelines, Where’s DDMAC’s Head At?
 - Red Means Stop, Green Means Go
 - Agents Need Monitoring
 - What About Public Relations Risks?
 
Read this article now. It’s FREE…
  PMN610-05
 Issue: Vol. 6, No. 10: November/December 2007
 Word Count: 2797 
            
		
![6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]](http://ec2-54-175-84-28.compute-1.amazonaws.com/pharma-mkting.com/wp-content/uploads/2021/04/6DigitalTools_600px-218x150.jpg)




![6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]](http://ec2-54-175-84-28.compute-1.amazonaws.com/pharma-mkting.com/wp-content/uploads/2021/04/6DigitalTools_600px-100x70.jpg)




